SECsense Logo

NewGenIvf Group Ltd: February 2025 SEC Form 6-K Insights & Key Announcements

$NIVF
Form 6-K
Filed on: 2025-02-20
Source
NewGenIvf Group Ltd: February 2025 SEC Form 6-K Insights & Key Announcements

Here are the key insights extracted from the provided section of the financial report:

  1. Document Type: This is a Form 6-K, which is a report filed by foreign private issuers to the SEC, indicating ongoing disclosures to investors.
  2. Company Information:
  • Name: NewGenIvf Group Limited
  • Address:
    • 36/39-36/40, 13th Floor, PS Tower
    • Sukhumvit 21 Road (Asoke), Khlong Toei Nuea Sub-district
    • Watthana District, Bangkok 10110, Thailand
  1. Reporting Period: The report pertains to the month of February 2025.
  2. SEC File Number: 001-42004, which is unique to NewGenIvf Group Limited, facilitating identification in SEC records.
  3. Annual Reporting Format: The company indicates it will file annual reports under Form 20-F, which is standard for foreign companies, rather than Form 40-F.
  4. Exhibit Included: The filing includes a press release as Exhibit 99.1, which may contain additional information or key announcements relevant to investors.
  5. Signature: The report is signed by Wing Fung Alfred Siu, who holds the position of Chairman of the Board and Director, indicating the authority behind the report.
  6. Date of Signing: February 20, 2025, which confirms the timing of the report's submission and potential relevance of the information contained within.

This section primarily establishes the company’s identity, the nature of the filing, and compliance with SEC reporting requirements, which is critical for investors and stakeholders analyzing the company’s operational transparency and regulatory adherence.